Client in need of expertise for IND development and FDA interaction for First-in-Human study

  • European SME beginning first discussions with the FDA regarding IND development and submission of an ADC product for an advanced cancer indication
  • Intent to gain agreement on completed nonclinical program to support first in-human (FIH) study